We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.22B
AUM Growth
+$476M
Cap. Flow
+$875M
Cap. Flow %
16.78%
Top 10 Hldgs %
15.66%
Holding
2,088
New
521
Increased
591
Reduced
504
Closed
422

Sector Composition

Rank Sector Weight
1 Technology 18.15%
2 Consumer Discretionary 13.85%
3 Healthcare 12.47%
4 Industrials 10.55%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNCA
1651
DELISTED
Genocea Biosciences, Inc.
GNCA
$63K ﹤0.01%
+9,061
New +$67.8K
DOTAW
1652
DELISTED
Draper Oakwood Technology Acquisition, Inc. Warrant
DOTAW
$62K ﹤0.01%
103,600
AST
1653
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$55K ﹤0.01%
40,016
+5,465
+16% +$8.37K
SRGA
1654
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$51K ﹤0.01%
369
-1,401
-79% -$193K
OIG
1655
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$50K ﹤0.01%
+426
New +$46.9K
AUTO
1656
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$49K ﹤0.01%
11,050
-64,143
-85% -$239K
TURN
1657
DELISTED
180 Degree Capital
TURN
$47K ﹤0.01%
+6,829
New +$42.9K
AFMD
1658
DELISTED
Affimed
AFMD
$45K ﹤0.01%
+2,712
New +$57.2K
CRNT icon
1659
Ceragon Networks
CRNT
$198M
$43K ﹤0.01%
12,050
-13,910
-54% -$43.2K
AMRN
1660
Amarin Corp
AMRN
$304M
$40K ﹤0.01%
656
-2,255
-77% -$140K
NRXPW
1661
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$40K ﹤0.01%
105,000
GSS
1662
DELISTED
Golden Star Resources Ltd.
GSS
$36K ﹤0.01%
10,693
-3,389
-24% -$11.5K
VIRX
1663
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$33K ﹤0.01%
+450
New +$40.1K
BCACW
1664
DELISTED
Bison Capital Acquistion Corp Warrant
BCACW
$32K ﹤0.01%
75,000
NNA
1665
DELISTED
Navios Maritime Acquisition Corporation
NNA
$19K ﹤0.01%
+2,044
New +$23K
MTNB icon
1666
Matinas BioPharma
MTNB
$1.73M
$14K ﹤0.01%
+656
New +$19K
AAT
1667
American Assets Trust
AAT
$1.39B
-49,670
Closed -$1.66M
ADAP
1668
DELISTED
Adaptimmune Therapeutics
ADAP
-50,337
Closed -$565K
AEP icon
1669
American Electric Power
AEP
$68.6B
-6,178
Closed -$424K
AGEN
1670
Agenus
AGEN
$304M
-4,431
Closed -$410K
AIZ icon
1671
Assurant
AIZ
$14.5B
-7,682
Closed -$702K
AJG icon
1672
Arthur J. Gallagher & Co
AJG
$64.3B
-6,581
Closed -$452K
ALE
1673
DELISTED
Allete
ALE
-4,664
Closed -$337K
ALG icon
1674
Alamo Group
ALG
$2.05B
-3,609
Closed -$397K
ALGN icon
1675
Align Technology
ALGN
$12.1B
-8,745
Closed -$2.2M

Similar funds

Oxford Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Oxford Asset Management held 2,088 positions worth $5.22B, up 10% from $4.74B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oxford Asset Management deployed $875M of net new capital in Q2 2018, opening 521 new positions and adding to 591 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 735,572 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $59.4M trimmed.

  • Oxford Asset Management's largest Q2 2018 buy was Twenty-First Century Fox, Inc. Class B: 735,572 shares worth $36.3M.
  • Oxford Asset Management added most to Envision Healthcare Holdings Inc in Q2 2018, an estimated $86.9M increase.
  • Oxford Asset Management's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $59.4M.
  • Oxford Asset Management fully exited Time Warner Inc in Q2 2018, selling an estimated $105M.
  • Oxford Asset Management's ten largest holdings make up 16% of its $5.22B portfolio in Q2 2018.
  • Oxford Asset Management opened 521 new positions and closed 422 in Q2 2018.
  • Oxford Asset Management's portfolio value rose 10% quarter-over-quarter to $5.22B.

Based on Oxford Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.